Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.53B | 33.71B | 30.47B | 27.45B | 27.39B | 25.41B |
Gross Profit | 4.80B | 5.17B | 5.01B | 2.55B | 1.39B | 381.00M |
EBITDA | 2.79B | 4.12B | 3.62B | 3.89B | 1.78B | 398.00M |
Net Income | 274.00M | 1.38B | 656.00M | 943.00M | -1.05B | -3.29B |
Balance Sheet | ||||||
Total Assets | 95.10B | 104.08B | 98.40B | 94.11B | 92.50B | 92.12B |
Cash, Cash Equivalents and Short-Term Investments | 3.50B | 4.05B | 3.97B | 4.45B | 5.29B | 5.29B |
Total Debt | 27.36B | 26.78B | 25.72B | 27.69B | 26.69B | 21.90B |
Total Liabilities | 53.74B | 61.32B | 56.79B | 54.89B | 53.81B | 52.74B |
Stockholders Equity | 40.35B | 41.72B | 40.65B | 38.36B | 37.81B | 38.39B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -2.27B | 1.12B | -4.58B | -5.01B | -2.66B |
Operating Cash Flow | 0.00 | 5.08B | 5.53B | 449.00M | -1.12B | 2.89B |
Investing Cash Flow | 0.00 | -5.57B | -3.65B | -2.15B | -3.56B | -2.94B |
Financing Cash Flow | 0.00 | 604.00M | -2.36B | 894.00M | 4.66B | 1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥13.26B | 7.62 | 0.30% | 2.97% | -16.90% | ||
71 Outperform | ¥250.34B | 11.04 | 2.04% | 7.94% | -5.97% | ||
65 Neutral | ¥18.76B | 16.27 | 0.86% | -0.82% | 12.28% | ||
64 Neutral | ¥18.98B | 13.72 | 1.28% | 10.64% | 110.16% | ||
63 Neutral | ¥43.20B | 8.39 | 2.84% | 0.92% | 55.82% | ||
60 Neutral | ¥44.04B | 14.41 | 2.02% | -1.86% | -2.54% | ||
58 Neutral | HK$14.03B | 4.45 | -3.01% | 7.32% | 3.67% | -54.16% |